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Bronchocentric granulomatosis due to 
AspergiZZus terreus in an immunocompetent 
and non-asthmatic woman 
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Department of Pulmonary Medicine, National Sanatorium Matsue Hospital, Mafsue, Japan 
This is the first report of bronchocentric granulomatosis due to Aspergillus terreus in a healthy and non-asthmatic 
74-year-old Japanese woman. Following identification of the fungus, oral itraconazole therapy was begun after 
intrabronchial infusion of amphotericin B. No recurrence has occurred after treatment for 24 months. We should 
consider the possibility of bronchocentric granulomatosis including Aspergillus terreus, when an intrabronchial 
lesion is found even in a healthy and non-asthmatic person. Oral itraconazole after intrabronchial infusion of 
amphotericin B seems to be effective in such cases. 
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Introduction 
Aspergillus species are ubiquitous and occur worldwide. 
Most case of the previous reports describe infection 
with Aspergilhs fumigatus and A. flavus. Invasive pulmon- 
ary aspergillosis caused by A. terveus has also been repor- 
ted in immunocompromised or immunocompetent hosts. 
Although there have been some reports of intrabronchial 
aspergillosis caused by other fungi, this is the first case of 
bronchocentric granulomatosis due to A. tevreus in an 
immunocompetent and non-asthmatic woman. 
Case Report 
In January 1997, a healthy and non-asthmatic 74-year-old 
woman was admitted to our hospital for further examina- 
tion of the right upper nodular opacity. The results of 
laboratory tests on admission were normal and she had no 
immunological defects. Serum IgE and MAST (multiple 
antigen simultaneous test) were aspergillus was normal. 
Serum aspergillus antigen (latex agglutination test, SRL- 
INC. Co, Japan) was negative, with a reported specificity of 
96.2 % and a sensitivity of 97.6 % (1). Serum aspergillus 
antigen was negative test after 3 months was negative. 
Routine bacteriological, fungal and mycobacterial cultures 
of sputum were negative. A chest radiograph revealed a 
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nodular opacity in the right upper lobe [Fig. l(a)]. CT scam 
of the thorax showed a branching band-like opacity in the 
right B2 [Fig. I(b)]. Fibre-optic bronchoscopy was per- 
formed. The transbronchial lung biopsy specimen con- 
tained hyphal fungal elements and a 3-day culture of the 
biopsy material on Sabouraud dextrose agar (Nissui 
Pharmaceutical Co, Inc., Japan) yielded five yellowish- 
brown cotton-like colonies. The fungal isolates were stained 
with lactophenol cotton blue stain and microscopic 
examination revealed conidiophores with multiple phialides 
and metulae, findings characteristic of A. terreus. The 
biopsy tissue showed an inflammatory granuloma with 
necrosis and hyphal fungal elements (Fig. 2). 
Intrabronchial infusion of amphotericin B (10 mg) was 
repeated five times. Treatment with oral itraconazole at a 
dosage of 100 mg day-’ was begun in February 1997. 
Though chest radiographs showed transient opacity of the 
right upper lobe, which is suspectedly a reaction to lysis of 
the fungus, this resolved 3 months later. After then, the 
chest radiographs showed no significant changes. Itracona- 
zole therapy was continued for 12 months without 
recurrence for 24 months. 
Discussion 
Aspevgillus tevreus is a ubiquitous fungus usually acquired 
by inhalation of airborn spores. Although invasive pul- 
monary aspergillosis (2-5) and allergic bronchopulmonary 
aspergillosis (6-S) have been reported, this is the first case 
of bronchocentric granulomatosis (BCG) due to A. terveus 
in immunocompetent and non-asthmatic woman. BCG is a 
descriptive term coined by Liebow in 1973 (9) to refer to an 
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uncommon histological reaction chiefly involving the small 
bronchi and bronchioles. 
A. terreus is being identified with increasing frequency in 
post-operative cardiac surgery patients and immunocom- 
promised patients (3,4). Our patient had neither abnormal 
laboratory data nor evidence of immunological abnormal- 
ities. Vincken (10) reported that A. ferreus may be a more 
common human pathogen than previously thought. Also, 
several recent reports of invasive aspergillosis other than A. 
terreus in patients without apparent defects in their immune 
system have been published (11,12). Therefore, we should 
consider the possibility of fungal infection, including A. 
terreus, when we find intrabronchial lesions in a previously 
healthy person. 
Goldberg (13) reported successful treatment of pulmon- 
ary Pseudallesheria boydii and A. terreus infections with 
oral itraconazole. Corticosteroids are the mainstay of 
treatment for BCG and there is little evidence that 
fungicidal therapy is effective (14). On the other hand, 
allergic bronchopulmonary aspergillosis (15) and aspergil- 
loma (16,17) can progress to invasive aspergillosis. We have 
previously reported a ‘case of intrabronchial pseudallesher- 
iasis (18) which’progressed to lobar pneumonia despite oral 
itraconazole (19). Therefore, we chose oral itraconazole 
therapy after intrabronchial infusion of amphotericin B, a 
combination which was effective without recurrence. 
FIG. 1. (a) Chest radiograph showing a band-like opacity of 
the right B’. CT scan of the thorax showing an 
intrabronchially branching, band-like opacity in the right 
B’a. 
FIG. 2. Endobronchial biopsy specimen from the intrabronchial lesion containing fungal hyphae of A. terreus. Bar indicates 
100pm. Grocott’s methamine silver stain; original magnification x 100 reproduced at 100%. 
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